When marked for degradation, surface receptor and transporter proteins are internalized and delivered to endosomes where they are packaged into intralumenal vesicles (ILVs). Many rounds of ILV formation create multivesicular bodies (MVBs) that fuse with lysosomes exposing 5 ILVs to hydrolases for catabolism. Despite being critical for protein degradation, the molecular underpinnings of MVB-lysosome fusion remain unclear, although machinery underlying other lysosome fusion events is implicated. But how then is specificity conferred? And how is MVB maturation and fusion coordinated for efficient protein degradation? To address these questions, we developed a cell-free MVB-lysosome fusion assay using S. cerevisiae as a model.
INTRODUCTION
Endocytosis is critical for regulating surface expression levels of polytopic proteins such as transporters and receptors for cellular signaling and survival in all eukaryotic organisms.
Proteins destined for degradation are labeled with ubiquitin and cleared from the surface by 5 invagination of the plasma membrane to form early endosomes. Through membrane fusion events, early endosomes deliver cargo proteins to an endosomal compartment where they encounter the ESCRT (Endosomal Sorting Complexes Required for Transport) machinery that sorts them into intraluminal vesicles (ILVs). Many rounds of ILV formation produce a multivesiclular body (MVB; Huotari and Helenius, 2011; Schmidt and Teis, 2012) , that when 10 mature, fuses with the lysosome to expose the ILVs to lumenal hydrolases for catabolism ( Piper and Katzmann, 2007; Luzio et al., 2010) . Although critical for surface protein degradation, we still do not understand many aspects of this terminal step of the endocytic pathway in molecular detail. 15 However, based on results primarily acquired using genetic approaches and microscopy, a model has emerged describing the mechanisms underlying MVB-lysosome fusion that are thought to be conserved in all eukaryotic species (reviewed by Luzio et al., 2010; Balderhaar and Ungermann, 2013) . MVBs contain two paralogs of almost every component of the fusion machinery (Kümmel and Ungermann, 2014) . One set (the Rab5 20 module) is required for endosome membrane fusion events responsible for anterograde membrane trafficking to the MVB, for surface protein delivery and organelle biogenesis. The second set (Rab7 module) is proposed to mediate MVB-lysosome fusion. However, most components of the latter set also drive homotypic lysosome fusion (Wickner, 2010; Wickner and Rizo, 2017) , provoking the question: What distinguishes these two fusion events?
RESULTS

A new cell-free assay to measure MVB-vacuole membrane fusion
We designed our new cell-free MVB-vacuole membrane fusion assay based on a strategy 5 originally devised by Jun and Wickner (2007) to study homotypic vacuole fusion that relies on the reconstitution of β-lactamase upon luminal content mixing ( Figure 1A) : To target the first fusion probe to the MVB lumen, we fused the C-terminus of the endosomal Qa-SNARE Pep12 to the proto-oncogene product c-Fos followed by the ω-subunit of β-lactamase (Pep12-Fos-Gsω). To target our second fusion probe the vacuole lumen, we fused the targeting sequence of 10 lysosomal protease carboxypeptidase Y (CPY; first 50 amino acids) to Jun, a cognate binding partner of c-Fos, followed by the α-subunit of β-lactamase (CPY50-Jun-Gs-α). We then expressed each probe in separate yeast strains (deficient of vacuolar proteases to prevent probe degradation) to prevent probe interaction in vivo. After isolated organelles from each strain are combined and undergo lipid bilayer merger in vitro, lumenal contents mix allowing 15 Jun and c-Fos to interact driving the complementary halves of β-lactamase together to reconstitute enzyme activity. Reconstituted β-lactamase activity is then measured by monitoring nitrocefin hydrolysis (by recording absorbance at 492 nm over time) to quantify MVB-lysosome fusion. 20 To confirm that the fusion probes were properly localized within cells, we generated yeast strains expressing versions of the probes tagged with GFP at their C-termini, stained them with FM4-64 to label vacuole membranes and imaged them using fluorescence microscopy ( Figure 1B) . The Pep12-GFP fusion protein appeared on puncta consistent with MVB localization as reported previously (Becherer et al., 1996) , whereas the CPY50-GFP fusion 25 protein was found within the vacuole lumen. Next, we fractionated cellular membranes by sucrose gradient ( Figure S1A ) and used western blot analysis to confirm that Pep12-Fos-Gs-ω is found in similar fractions (9-12) as Vps10, a resident protein on MVBs (Marcusson et al., 1994) , as well as endogenous Pep12. CPY50-Jun-Gs-α is not found in fractions containing the MVB fusion probe, but rather in fractions (3-4) containing Nyv1, a R-SNARE that is exclusively found 30 on vacuole membranes (Wen et al., 2006) , and endogenous CPY a vacuole resident protein.
We next collected fractions containing MVB membranes (9-12) from Pep12-Fos-Gs-ω expressing cells or vacuole membranes (3-4) from CPY50-Jun-Gs-α expressing cells and mixed them together under conditions that promote the homotypic vacuole membrane fusion reaction in vitro (see Jun and Wickner, 2007) . Unfortunately these preparations were fusion 35 incompetent ( Figure S1B ). Thus, we sought an alternative method to isolate the organelles to optimize our cell-free fusion assay.
Based on a method to isolate intact, fusogenic vacuoles from yeast cells (see Conradt et al., 1992) , we decided to use a 4-step ficoll gradient to isolate both MVBs and vacuoles in the same preparations. Although vacuoles are known to accumulate at the 0-4 % ficoll interface, it is not clear whether MVBs also migrate to this layer during centrifugation. Thus, we performed 5 ficoll-based fractionation experiments using cells expressing GFP-tagged versions of the fusion probes, collected organelles that accumulated at the 0-4% ficoll interface, and imaged them ( Figure 1C ). Pep12-GFP is present in the preparation and localizes to small puncta adjacent to vacuole membranes reminiscent of MVB structures, whereas CPY50-GFP is found within the lumen of isolated vacuoles, consistent with their distributions in living cells. We also observed 10 the presence of our fusion probes (Pep12-Fos-Gs-ω or CPY50-Jun-Gs-α) in this fraction by western blot analysis ( Figure 1D ). Markers of both MVBs (Vps10, endogenous Pep12) and vacuoles (Nyv1, endogenous CPY), and fusogenic proteins (e.g. Ypt7, Vps41, Vps33 and Nyv1)
were also present confirming that both organelles are found in this preparation and are likely fusogenic. We next mixed equal proportions of organelles isolated from cells expressing only 15 the MVB fusion probe or only the vacuole fusion probe in fusion buffer that mimics cytosolic conditions (125 mM KCl, 5 mM MgCl2, 200 mM sorbitol, 20 mM PIPES, pH 6.80). We added 1 mM ATP to trigger membrane fusion and incubated reactions at 27˚C for up to 90 minutes.
Upon measuring reconstituted β-lactamase activity ( Figure 1E ), we observed robust nitrocefin hydrolysis indicative of heterotypic fusion, showing a signal up to 10 fold greater than 20 background (i.e. reactions run without ATP or left on ice). Rates of heterotypic fusion were comparable to those observed for homotypic vacuole fusion, an additional indication that this new assay may be reliably used to study the heterotypic fusion reaction in detail.
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Sec17, Ypt7 and HOPS drive MVB-vacuole fusion in vitro
With this new assay in hand, we next tested the prevailing model of MVB-vacuole fusion ( Figure 2A ), which predicts that Sec17, Ypt7 and HOPS orchestrate this event (Balderhaar et al., 2010 (Balderhaar et al., , 2013 . The α-SNAP ortholog Sec17 both unravels cis-SNARE complexes and, through 30 HOPS binding, promotes SNARE-zippering during homotypic fusion (Schwartz and Merz, 2009; Wickner and Rizo, 2017) . As the only α-SNAP ortholog in S. cerevisiae, it is hypothesized to also MVB-vacuole fusion. Indeed, adding purified anti-Sec17 antibody, at concentrations that block homotypic fusion, also prevents heterotypic fusion (Figure2B), suggesting a role in both events. We next confirmed that Ypt7 and HOPS (the Rab7 module in yeast) also underlie both 35 fusion events ( Figure 2B ): Addition of the Rab-GTPase inhibitors rGdi1 (a Rab-GTPase chaperone that extracts Rab proteins from membranes) or rGyp1-46 (the active domain of the Rab-GAP protein Gyp1; see Brett and Merz, 2008) blocks both fusion events, confirming that Rab-GTPase activation is required. Addition of purified anti-Ypt7 antibody, at levels that block homotypic fusion, inhibited heterotypic fusion, confirming that activation of this specific Rab is needed for both fusion events. The HOPS holocomplex contains six protein subunits, two of which are unique (Vps41 and Vps39) and four (Vps33, Vps11, Vps18 and Vps16) that are shared 5 with CORVET (class C core vacuole/endosome tethering complex), a similar multisubunit tethering complex within the Rab5 module also found on endosomes (Peplowska et al., 2007; Nickerson et al., 2009; Plemel et al., 2012) . Addition of purified anti-Vps33 antibody blocks both fusion events ( Figure 2B ), suggesting involvement of either complex. Purified anti-Vps41 antibody also blocked heterotypic and homotypic fusion ( Figure 2B ), confirming that HOPS, 10 specifically, contributes MVB-vacuole fusion.
Ypt7 and HOPS drive the docking subreaction of homotypic vacuole fusion whereby fusogenic proteins and lipids assemble into a ring at the vertex between closely apposed membranes (Wang et al., 2002; Wang et al., 2003; Fratti et al., 2004) . This unique arrangement 15 causes the portion of membrane within the vertex ring, called the boundary, to form an extended, flat interface between apposing membranes that can be visualized by transmission electron microscopy (Mattie et al., 2017) . Given that same Rab7 module mediates heterotypic fusion, we hypothesized that similar boundaries may form during the docking stage of MVBvacuole fusion. To test this hypothesis, we visualized in vitro heterotypic fusion reactions by 
Trans-SNARE complexes distinguish MVB-vacuole from homotypic vacuole fusion events
The final stage of the organelle fusion reaction is lipid bilayer merger driven by complete trans-SNARE-complex zippering (Nichols et al., 1997) . For homotypic vacuole fusion, trans-SNARE 35 complexes are minimally composed of the three Q-SNAREs -the syntaxin ortholog Vam3 (Qa), Vti1 (Qb) and the SNAP25 ortholog Vam7 (Qc) -and the R-SNARE Nyv1, a synaptobrevin ortholog (Wickner, 2010; Wickner and Rizo, 2017 (Becherer et al., 1996; von Mollard et al., 1997; Gerrard et al., 2000; Gurunathan et al., 5 2000) suggesting that trans-SNARE complexes mediating heterotypic and homotypic fusion are different, whereby the MVB donates either Pep12 or Snc2 (but not both To test this hypothesis, we isolated SNARE complexes using an approach that ensures they form in trans during the membrane fusion reaction in vitro (see Collins and Wickner, 2007; 15 Schwartz and Merz, 2009): We mixed organelles missing NVY1 and expressing Pep12 fused to calmodulin-binding protein (CBP::Pep12) with organelles missing PEP12 under fusogenic conditions, and then conducted pull-down assays and western blot analysis to identify SNARE proteins in complex with CBP::Pep12 ( Figure 3A ). We also repeated the experiment with CBP::Vam3 for comparison and as a positive control (Schwartz and Merz, 2009 ). As expected, 20 both trans-SNARE complexes contained Vti1 and Vam7, but only under fusogenic conditions (with ATP; Figure 3B ). Very little Vma3 co-purified with CBP::Pep12, and no Pep12 was found in CBP::Vam3 complexes, confirming the presence of distinct Q-SNARE bundles. Importantly, the vacuolar R-SNARE Nyv1 was found in both complexes, but not the endosomal R-SNARE Snc2, confirming that Pep12-Vti1-Vam7-Nyv1 complexes form in trans during organelle fusion in 25 vitro.
Addition of purified, recombinant Vam7 protein (rVam7, the soluble Qc-SNARE) to isolated vacuoles drives formation vacuolar trans-SNARE complexes promoting homotypic fusion without ATP (Thorngren et al., 2004) . Given that Vam7 is found in both trans-SNARE 30 complexes, we next tested if rVam7 could also stimulate assembly of Pep12-containg complexes. As expected, rVam7 drives formation of both trans-SNARE complexes ( Figure 3B ), suggesting that it contributes to heterotypic as well as homotypic fusion. Vps33, a component of HOPS and SM-protein ortholog, binds SNAREs and initiates trans-SNARE complex formation during homotypic vacuole fusion by threading the Qa-SNARE Vam3 with the R-SNARE Nyv1 35 (Baker et al., 2015) . Recombinant Vps33 protein was also shown to thread Pep12 and Nyv1 protein in vitro (Lobingier et al., 2012) . Thus, we also tested whether Vps33 binds to trans-SNARE complexes thought to mediate MVB-vacuole fusion. Indeed, Vps33 bound to Pep12-Nyv1-containing as well as Vam3-Nyv1-contianing complexes ( Figure 3B ), suggesting that HOPS initiates formation of Pep12-Vti1-Vam7-Nyv1 complexes in trans to drive MVB-vacuole fusion.
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To demonstrate that this distinct trans-SNARE complex drives MVB-vacuole fusion, we next tested the role of these SNAREs in this process using our new in vitro assay. First, we added different purified antibodies raised against the Qa-SNAREs Pep12 or Vam3 to organelle fusion reactions ( Figure 3C ). As predicted, increasing concentrations of anti-Pep12 antibody preferentially blocked heterotypic fusion, whereas anti-Vam3 antibody preferentially inhibited Stevens, 2010; Russell et al., 2012), we mixed organelles isolated from these strains with organelles from wild type cells expressing the vacuolar fusion probe and conducted in vitro fusion assays ( Figure 4B ). This approach ensured that vacuoles were fusogenic, as deleting components of ESCRTs blocks the CPY and CPS (carboxypeptidase-S) biosynthetic pathways that supply vacuoles with fusion proteins (Katzmann et al., 2001 ) -noting that this also prevented us from assessing effects of these mutants on homotypic vacuole fusion in vitro. As predicted, deleting any of the three ESCRT components inhibited MVB-vacuole fusion, 5 indicating that blocking any stage of ILV formation impairs heterotypic fusion. hypothesis, we took three approaches: First, we added GTPγS, a non-hydrolyzible GTP analog, to activate all GTPases (including Ypt7) and found that it rescued heterotypic fusion defects caused by deleting components of ESCRTs ( Figure 4B ). Next, we added rVam7 in place of ATP to stimulate fusion, as it bypasses the requirement for Ypt7 (Thorngren et al., 2004) , and found that it also rescued fusion defects ( Figure 4B ). These results also confirm that Ypt7 and SNAREs 20 are functional, but not engaged, on aberrant endosomal compartments isolated from ESCRT mutants. Finally, to demonstrate that Ypt7 is targeted, we introduced a Q68L mutation in Ypt7 to render it constitutively active (see Brett et al., 2008) in cells lacking VPS23. After confirming the fusion probe was properly localized, we found that it too rescued MVB-lysosome fusion defects caused by this mutation (Figures 4A and 4C) . Furthermore, addition of GTPγS did not 25 further enhance heterotypic fusion in the presence of Ypt7 Q68L, suggesting that Ypt7 was the likely the target of GTPγS that rescues fusion when ESCRT function is impaired. In all, these findings demonstrate that the ESCRT machinery activates Ytp7 to trigger MVB-vacuole fusion.
DISCUSSION
A reliable cell-free assay to study MVB-lysosome fusion
Here we describe a new cell-free assay to measure MVB-vacuole membrane fusion based on 5 reconstitution of lumenal β-lactamase ( Figure 1 ). The method of organelle isolation was crucial for success, and although MVBs are not separated from vacuoles in these preparations, targeting the fusion probes to each organelle in separate yeast strains and mixing them later ensures that reconstituted β-lactamase activity represents only fusion that occurs in vitro under controlled conditions. Importantly, this new assay offers a reliable method to study the MVB-10 vacuole membrane fusion reaction in detail, by providing many experimental advantages:
First, it is quantitative, robust (with a signal-to-noise ratio up to 10:1) and allows kinetic analysis. Second, it is a simple, colorimetric alternative to fluorescence-based assays limited by resolution and accuracy of colocalization methods offered by light microscopy (offering only 15 3:1 signal-to-noise; Cao et al., 2015) or assays that require use of radioactive reagents, e.g. 125 Ilabeled biotin (offering only 4:1 signal-to-noise; Pryor et al., 2004) . Third, it overcomes limitations associated with using genetic approaches to study this event, whereby mutations hypothesized to block MVB-vacuole fusion also impair carboxypeptidase-Y and -S biosynthetic pathways that feeds vacuoles resident proteins, possibly introducing defects that indirectly 20 affect vacuole fusogenicity in vivo (see Robinson et al., 1988; Raymond et al., 1992) . This is achieved by mixing organelles isolated from mutants with those from wild type cells; an approach that may also be used to define contributing mechanisms from each organelle. (4) It overcomes the need to purify organelles to homogenity, as required to make inferences from methods that do not selectively label a single organelle population, e.g. lipid dyes (R-18) for 25 fluorescence dequenching-based lipid-mixing fusion assays (e.g. Jun and Wickner, 2007), or internalized protein reagents fluorescence dyes that label multiple endocytic compartments (e.g. Morvan et al., 2009 ). Fifth, unlike most cell-free endosome or MVB fusion assays (e.g. Vida and Gerhardt, 1999), it does not require addition of cytosol indicating that all machinery necessary for fusion co-purifies with organelles facilitating their study. Finally, it offers the 30 advantages of changing the reaction buffer conditions to simulate changes in the "cytoplasm" to better understand how heterotypic fusion is regulated or using protein reagents to overcome issues associated with plieotropy, allowing study of contributions from gene products predicted to have multiple functions at multiple site in cells, e.g. Sec17.
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As an alternative to MVB-vacuole fusion, MVBs may be engulfed by the vacuole membrane and internalized by a closure event mediated by the shared fusion machinery, akin to autophagy. Within the lumen, the MVB perimeter membrane would be catabolized by acid hydrolases facilitating content mixing and interaction of the fusion probes. However, three observations exclude the possibility that MVBs are internalized by this autophagic mechanism:
(1) No intermediates or products of autophagy were observed in the fusion reactions by TEM or fluorescence microscopy (e.g. an invagination of the vacuole membrane containing an MVB, 5 an intact MVB encased by a double lipid bilayer within the vacuole lumen; also see Mattie et al., 2017) . Nor did we observe MVBs trapped between apposing membranes at large contact sites between adjacent vacuolar lysosomes, an area that internalized into the lumen upon fusion at the vertex ring (Wang et al., 2002; McNally et al., 2017) .
(2) Polytopic proteins that exclusively reside within MVB perimeter membranes appear on membranes of large vacuoles 10 over time during the fusion reaction in vitro. Furthermore, degradation of these proteins is not observed, excluding the possibility that the MVB perimeter membrane is exposed to lumenal hydrolases (e.g. GFP-tagged Nhx1; M.A. Karim and C.L. Brett, unpublished results). (3) We find that the MVB contributes at least one SNARE, Pep12, to trans-SNARE complexes that drive membrane fusion, suggesting that the underlying machinery is distinct from homotypic vacuole 15 fusion. Therefore, it is unlikely to mediate closure of the vacuole membrane, which would be analogous to a homotypic vacuole fusion event. Thus, consistent with previous reports (e.g. Futter et al., 1996; Bright et al., 2005) , we are confident that observed reconstituted βlactamase activity reflects genuine merger between MVB perimeter and vacuole membranes.
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The Qa-SNARE Pep12 is implicated in earlier endosome fusion events required for MVB maturation (Kümmel and Ungermann, 2014) . Thus, to better understand this process, we also attempted to measure homotypic endosome fusion in vitro by swapping the targeting sequence in the vacuolar fusion probe re-routing it to the endosome (i.e. CPY50 was exchanged with Pep12 rendering Pep12-Jun-Gs-α). However, we did not detect reconstituted 25 β-lactamase activity over background levels (data not shown). We suspect that this is due to our method of organelle isolation: From electron and fluorescence micrographs, endosomes and MVBs seem less abundant than vacuoles. When also considering that vacuoles are much larger than MVBs, we suspect that endosomes within the in vitro fusion reaction were more likely to encounter a vacuole than another endosome, decreasing possible endosome-endosome fusion 30 events to a level below detectability by this assay. Future experiments will involve further purification of endosomes to overcome this technical issue. With this in mind, the same approach could be used to study other organelle membrane fusion events by swapping the targeting sequence in the fusion probe(s) and purifying organelles using a method that does not damage membranes (e.g. isolation by floatation, not sedimentation) and ensures 35 fusogenicity (e.g. low osmolarity, not by sucrose gradient; see Figure S1 ).
A new model describing MVB-lysosome fusion
Here we definitively show that Sec17, Ypt7 and the HOPS complex are necessary for membrane fusion between wild type, intact MVBs and vacuoles ( Figure 2B) . These proteins donates the R-SNARE Nyv1. We also demonstrate that these SNAREs are necessary or sufficient for MVB-vacuole fusion using three approaches ( Figure 3C and D) : knocking out NYV1 blocks fusion, adding purified antibodies raised against Nyv1 or Pep12 blocks fusion, or adding purified, recombinant Vam7 protein drives fusion. Importantly, we also measure homotypic vacuole fusion as a control (Figures 1 -3) to demonstrate that reagents targeting 25 shared machinery are effective at concentrations used, and we also exclude the possibility that the inverse trans-SNARE complex arrangement contributes to this process, i.e. a complex containing the Qa-SNARE Vam3 (in complex with Vti1 and Vam7) from the vacuole and R-SNARE Snc2 donated by the MVB (Figure 3) . These findings are consistent with numerous previous reports: MVB-vacuole fusion. Third, overexpression of VAM3 suppresses membrane trafficking defects in pep12∆ yeast cells (Götte and Gallwitz, 1997), suggesting that Pep12 and Vam3 can be exchanged within SNARE complexes as we show in Figure 3B . Forth, consistent with our 5 findings, endosomal Q-SNAREs and a lysosomal R-SNARE are proposed to mediate endosome-lysosome fusion in mammalian cells (Pryor et al., 2004) , suggesting this mechanism is evolutionarily conserved. Finally, Vps33 is known to function at the endosome and vacuole (Subramanian, 2004) and studies conducted with purified proteins demonstrate that the SMprotein Vps33 binds to Vam3 or Pep12 with equal affinity to promote templating with Nyv1 10 (Lobingier and Merz, 2012; Baker et al., 2015) . Here we show that Vps33 binds SNARE complexes containing Pep12-Nyv1 or Vam3-Nyv1 ( Figure 3B ) and MVB-vacuole fusion requires Vps33 and Pep12 but not Vam3 (Figures 2B and 3C ). Thus, we conclude that Vps33 within the HOPS complex promotes Pep12-Vti1-Vam7-Nyv1 complex formation in trans to drive MVBlysosome fusion ( Figure 4D ).
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The second advance is our discovery that fusogenic proteins and lipids may assemble into a ring at the interface between docked MVB and vacuole membranes. During homotypic vacuole fusion, Ypt7, HOPS and SNAREs assemble into a ring at the vertex between apposed membranes, creating a flat circular boundary area at the site of contact between organelle 20 membranes (Wang et al., 2003; Mattie et al., 2017) . We observed similar flattened interfaces between MVBs and vacuoles by TEM ( Figure 2C) . Given that most components of the underlying fusion machinery are shared (Sec17, Ypt7, HOPS and 3 of 4 SNAREs), we reason that they also drive formation of this same topological arrangement to mediate MVB-vacuole fusion. Importantly, during homotypic vacuole fusion, lipid bilayer merger occurs at the vertex 25 ring causing the entrapped boundary membrane to be internalized as an intralumenal fragment (Wang et al., 2002; Mattie et al., 2017; Karim et al., submitted) . Vacuolar polytopic proteins are selectively sorted into the boundary and, upon membrane fusion, are internalized and degraded by lumenal hydrolases (McNally et al., 2017) . This process, called the ILF (IntraLumenal Fragment) pathway requires Ypt7 and HOPS for protein sorting. Thus, it is 30 tempting to speculate an ILF is also formed during MVB-vacuole fusion. If so, this could explain the presence of large ILVs within MVBs in cells lacking the ESCRT machinery (Stuffers et al., 2009 ). It would also allow organelles to selectively remove damaged or superfluous polytopic proteins for quality control or to remodel the protein landscape of the fusion product membrane for organelle identity and function.
ESCRTs trigger MVB-lysosome fusion by promoting Rab conversion
Here, we show that individually deleting VPS23, VPS326 or SNF7--components of ESCRT-I, -II and -III, respectively--prevents MVB-vacuole fusion in vitro ( Figure 4B ). Activating Ypt7 by introducing a Q68L mutation or adding GTPγS to reactions rescued fusion defects caused by 5 these mutations ( Figure 4B and C) . Although they perform unique roles in the pathway, deleting any of these complexes prevents ILV formation. We therefore reason that ILV formation itself triggers fusion with lysosomes (Russell et al., 2012) . But how does this occur?
Although the precise molecular mechanism remains unknown, previous work revealed 10 that active Vps21 and its GEF (Guanine Exchange Factor) Vps9 accumulate on aberrant endosome membranes in cells lacking ESCRT function (Russell et al., 2012) . Although Ypt7 is present, its effector Vps41 (and presumably the HOPS complex) is absent from these compartments. These findings led to the hypothesis that a Rab conversion mechanism may couple MVB maturation with vacuole fusion, whereby Vps21 inactivation triggers activation of 15 Ypt7 to promote anterograde trafficking. Vps9 is recruited to endosomal membranes by binding ubiquitin linked to internalized surface proteins (Shideler et al., 2015) . Normally these proteins are cleared from the perimeter membrane by ESCRTs, causing dissociation of Vps9 from the perimeter membrane and, in turn, Vps21 is inactivated linking MVB maturation to Rab conversion. However, ESCRT impairment causes ubiquitylated proteins to accumulate, Vps9 20 then remains and chronic activation of Vps21 prevent Rab conversion thus blocking MVBvacuole fusion (Russell et al., 2012; Shideler et al., 2015) . Although the mechanism that couples Vps21 and Ypt7 activities remains elusive, it likely involves stimulation of Msb3, a GAP that inactivates Vps21 (Lachmann et al., 2012) , Mon1-Ccz1, the GEF that activates Ypt7 (Nordmann et al., 2010) , and possibly BLOC-1 (biogenesis of lysosome-like organelles complex-1) to 25 coordinate GAP and GEF function on mature MVB membranes (Rana et al., 2015) . We will test this hypothesis in the near future using this new cell-free MVB-vacuole fusion assay to provide a comprehensive understanding of this process and to improve our knowledge of Rabconversion, which is thought to coordinate progressive membrane trafficking at most sites within eukaryotic cells.
30
As with the fusion machinery, ESCRTs and potential mediators of Vps21-Ypt7 conversion are evolutionarily conserved, suggesting the same mechanism likely underlies MVBlysosome fusion in metazoan cells (Saksena and Emr, 2009; Dennis et al., 2016) . Loss-offunction mutations in ESCRT components are linked to many human disorders, including 35 cancers and neurodegenerative diseases (Saksena and Emr, 2009) . Similar to phenotypes observed in S. cerevisiae, enlarged, abnormal endosome-like structures accumulate and surface protein degradation is impaired within human cells harboring ESCRT mutations, suggesting MVB-lysosome fusion is defective. Here we show that stimulating Ypt7, the yeast ortholog of human Rab7, overcomes this fusion defect. Although these compartments lack ILVs, this fusion event delivers internalized surface proteins to the vacuolar lysosome membrane where they are selectively degraded by the ILF pathway (McNally and Brett, 5 submitted). As it is proposed that inefficient surface receptor degradation underlies the etiology of these diseases, we hypothesize that developing therapeutics designed to activate Rab7 may represent a valid strategy for treatment.
MATERIALS AND METHODS
Yeast strains and reagents
We expressed all fusion probes in the Saccharomyces cerevisiae strain BJ3505 [MATα pep4: :HIS3 prbΔ1-1.6R his3-Δ200 lys2-801trp1-Δ101 (gal3) ura3-52 gal2 can1] because it is 5 devoid of vacuolar lumenal proteases that would otherwise degrade these proteins. To ensure high levels of protein expression, BJ3505 cells were transformed with two plasmids each containing a copy of a single fusion probe: For MVB-vacuole fusion, pRS406-Pep12-Fos-Gs-ω (pCB002) and pRS404-Pep12-Fos-Gs-ω (pCB003) to target the MVB, or pRS406-CPY50-Jun-Gsα (pYJ406-Jun) and pRS404-CPY50-Jun-Gs-α (pCB011) to target the vacuole. For homotypic 10 vacuolar lysosome fusion, the yeast strain expressing the MVB probe was replaced with one transformed with pRS406-CPY50-Fos-Gs-ω (pYJ406-Fos) and pRS404-CPY50-Fos-Gs-ω (pCB008) to target the vacuole instead. NYV1, VPS23, VPS36, and SNF7 were knocked out of BJ3505 cells using the Longtine method (Longtine et al., 1998) . To assess localization of fusion probes, we transformed wild type or mutant BJ3505 cells with pRS406-Pep12-pHluorin 15 (pCB046) to target the MVB lumen or pRS406-CPY50-GFP (pCB044) to target the vacuole lumen and imaged live cells by fluorescence microscopy. To evaluate trans-SNARE complexes, BJ3505 cells lacking NYV1 were transformed with pRS406-CBP-Pep12 (pCB045) to generate BJ3505-CBP-Pep12 nyv1Δ. BJ3505-CBP-Vam3 nyv1Δ was a gift from A.J. Merz (see Collins and Wickner, 2007) . 
Membrane fractionation by sucrose gradient
Yeast cells were grown in YPD overnight to OD600nm= 1.6/ml, harvested, and spheroplasted with lyticase for 30 minutes at 30°C. Spheroplasts were then sedimented and resuspended in 10 ml of TEA buffer (10 mM triethanolamine, pH 7.5, 100 mg/ml phenylmethylsulfonyl fluoride, 10 mM NaF, 10 mM NaN3, 1 mM EDTA, and 0.8 M sorbitol) and homogenized on ice by 5 Dounce homogenization (20 strokes). Cell lysates were centrifuged at 15,000 g for 20 minutes, and the resulting supernatant was then centrifuged at 100,000 g for 2 hours to sediment cellular membranes. Pellets were resuspended in 1 ml of TEA buffer and loaded onto a stepwise (20-70%) sucrose density gradient, and then centrifuged at 100,000 g for 16 hours at 4°C to separate different cellular membranes by density. Samples were collected from the top, 10 and each fraction was precipitated using 10% trichloroacetic acid, washed and resuspended in 100 μl of SDS-PAGE buffer. Fractions were then loaded into SDS-polyacrylamide gels and subjected to electrophoresis to separate proteins by size. Western blot analysis was performed to determine fractions that contain proteins of interest.
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Organelle isolation and cell-free fusion assay
Organelles were isolated from yeast cells by a ficoll floatation method as previously described (Haas, 1995) . Organelle membrane fusion was assessed using a modified version of a published assay that relies on split β-lactamase complementation upon lumenal content mixing (Jun and Wickner, 2007) . In brief, organelles were isolated from two separate strains that each vacuoles were pretreated with 0.2 mM GTPγS for 10 minutes at 27°C prior to addition to fusion reactions, or reactions were supplemented with 100 nM rVam7 and 10 μg/ml bovine serum albumin.
Trans-SNARE paring assay
Analysis of trans-SNARE complex formation was assayed as described (Schwartz and Merz, 2007) , whereby the levels of Nyv1 that co-immunoprecipitate with CBP-Pep12 or CBP-Vam3 5 was determined. Briefly, 45 μg of organelles each from CBY224 (BJ3505-CBP-Pep12 nyv1Δ) or BJ3505-CBP-Vam3 nyv1Δ and BJ3505 were incubated under fusion conditions for 60 minutes.
Reactions were then placed on ice for 5 minutes, and samples were centrifuged (11,000 g, 15 minutes, 4°C). Supernatants were decanted, and membrane fractions were resuspended in 560 μl solubilization buffer (20 mM Tris-Cl pH 7.5, 150 mM NaCl, 1 mM MgCl2 0.5% Nonidet P-40 10 alternative, 10% glycerol) with protease inhibitors (0.46 μg/ml leupeptin, 3.5 μg/ml pepstatin, 2.4 μg/ml pefabloc, 1 mM PMSF), and nutated for 20 minutes at 4°C. Reactions were centrifuged again (16,000 g, 20 minutes, 4°C) and supernatants collected. 10 % of the extracts were collected as input samples, and the remaining extracts were brought to 2 mM CaCl2. The CBP-Pep12-Nyv1 or CBP-Vam3-Nyv1 complexes were recovered with calmodulin sepharose 15 beads 4B (GE Healthcare) by nutating overnight at 4°C, collected by brief centrifugation (4,000 g, 2 minutes, 4°C), washed five times with sample buffer, and followed by bead sedimentation.
Bound proteins were eluted by boiling beads (95°C, 10 minutes) in SDS sample buffer containing 5 mM EGTA for SDS-PAGE analysis and immunoblotting.
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Western blot analysis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed using a Bio-Rad mini protein system (Bio-Rad Laboratories, Hercules, CA, USA). After separation, proteins were transferred onto a nitrocellulose membrane by wet transfer method at 12 V for 8 hours using a Royal Genie Blotter apparatus (Idea Scientific, Minneapolis, MN, USA).
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Membranes were blocked with 3% BSA in PBST buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 0.1% Tween-20) and then washed twice with PBST and incubated with primary antibody diluted to 1:1,000 in PBST for 1 hour at room temperature. Membranes were washed with PBST five times, and then incubated with HRP or FITC labeled goat antirabbit or anti-mouse IgG diluted 1:10,000 in PBST for 45 minutes at room temperature. After 30 an additional 5 washes with PBST, the membranes were probed to detect bound secondary antibody using GE Amersham Imager 600 for chemiluminescence or a Typhoon scanner for fluorescence (GE Healthcare, Piscataway, NJ, USA).
Fluorescence microscopy 35
Live yeast cells stained with FM4-64 to label vacuole membranes were prepared for imaging using a pulse-chase method as previously described (Brett et al., 2008) . For in vitro imaging, organelles isolated from strains expressing Pep12-pHluorin or CPY50-GFP were stained with 3 μM FM4-64 for 10 minutes at 27°C to label vacuole membranes. We used a Nikon Eclipse TiE inverted microscope equipped with a motorized laser TIRF illumination unit, Photometrics Evolve 512 EM-CCD camera, an ApoTIRF 1.49 NA 100x objective lens, and bright (50 mW) blue and green solid-state lasers operated with Nikon Elements software (housed in the Centre 5 for Microscopy and Cellular Imaging at Concordia University).
Transmission Electron Microscopy
Isolated organelles were processed for transmission electron microscopy (TEM) as previously described (Mattie et al., 2017) . Briefly, fusion reactions were incubated at 27°C for 30 minutes, 10 vacuoles were gently pelleted (5,000 g for 5 minutes) at 4°C and immediately fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) overnight at 4°C. Vacuole pellets were washed with 0.1 M sodium cacodylate (3 times, 10 minutes) and then fixed with 1% osmium tetroxide for two hours at 4°C. Pellets were washed with water (3 times, 5 minutes) followed by gradual dehydration in ethanol (30-100%) and 100% propylene oxide. Pellets were infiltrated 15 with epon:propylene oxide for 1 hour and then embedded in pure epon by polymerization (48 hours at 57°C). Samples were cut into 100 nm thick sections using an ultra diamond knife and Reichert Ultracut II microtome, loaded onto 200-mesh copper grids, and stained with uranyl acetate (8 minutes) and Reynold's lead (5 minutes). Sections were imaged at 120 kV using an fusion values measured using organelles isolated from nyv1∆ cells or from wild type cells in the presence of 2.2 µM purified anti-Nyv1 antibody. Fusion of organelles from wild type cells was also measured in the 10 presence of 100 nM rVam7 to stimulate fusion in place of ATP, with or without pretreatment with 1.8 µM anti-Sec17 to encourage SNARE complex formation (Thorngren et al., 2004) . Reactions were kept on ice to prevent fusion as negative control. Means ± S.E.M. shown (n ≥ 2). 
